Skip to content

13F-HR filed by Sio Capital Management, LLC

Sio Capital Management, LLC filed this 13F-HR for the quarter ended 2015-03-31, filed 2015-05-15, with 30 holding rows worth $175,729,000.

Accession
0001214659-15-004036
Filed
2015-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2015

A holdings report, 30 entries on the cover page, a total value of $175,729,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $175,729,000 with VALUE read as thousands by filing date, 13F file number 028-13691. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CELGENE CORP151020104COM525,000$60,522,000thousands by filing dateput
QUOTIENT LTDG73268107SHS1,123,641$19,102,000thousands by filing date
PFENEX INC717071104COM653,393$10,415,000thousands by filing date
Merck & Co.,Inc.58933Y105COM145,000$8,335,000thousands by filing date
Eli Lilly and Company532457108COM100,000$7,265,000thousands by filing dateput
ASTRAZENECA PLC SPONSORED ADR046353108ADR100,000$6,843,000thousands by filing dateput
UNITED THERAPEUTICS CORP DEL COM91307C102Stock34,700$5,983,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM58,000$5,236,000thousands by filing date
Johnson & Johnson478160104COM50,000$5,030,000thousands by filing dateput
ADAMIS PHARMACEUTICALS CORP00547W208COM NEW1,179,981$4,649,000thousands by filing date
Johnson & Johnson478160104COM45,000$4,527,000thousands by filing date
ADDUS HOMECARE CORP006739106COM189,466$4,362,000thousands by filing date
CERNER CORP156782104COM53,800$3,941,000thousands by filing dateput
AbbVie,Inc.00287Y109COM55,000$3,220,000thousands by filing date
UnitedHealth Group Inc91324P102COM26,500$3,135,000thousands by filing date
ARATANA THERAPEUTICS INC03874P101COM178,550$2,859,000thousands by filing date
CELLADON CORP15117E107Cmn138,800$2,629,000thousands by filing dateput
TRIPLE-S MGMT CORP896749108CL B112,400$2,235,000thousands by filing date
STEMLINE THERAPEUTICS INC85858C107COM140,000$2,026,000thousands by filing date
HERON THERAPEUTICS INC427746102COM137,100$1,995,000thousands by filing date
FORWARD PHARMA A/S34986J105SPONSORED ADR67,455$1,910,000thousands by filing date
AGILE THERAPEUTICS INC00847L100COM203,732$1,889,000thousands by filing date
HARVARD APPARATUS REGENER TE41690A106COM455,901$1,482,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM46,677$1,369,000thousands by filing date
SCYNEXIS INC COM NEW811292101Common Stock152,780$1,268,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock76,924$1,191,000thousands by filing date
TOKAI PHARMACEUTICALS INC COM88907J107Stock82,283$930,000thousands by filing date
INSPIREMD INC45779A309COM2,227,562$713,000thousands by filing date
MERIT MED SYS INC COM589889104Stock24,235$467,000thousands by filing date
BIODELIVERY SCIENCES INTL IN09060J106COM169,200$201,000thousands by filing datecall

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001214659-15-004036this filing2015-05-15acceptance time not in the bulk data set